Section 7: Cancer treatment services

Authorisation for A6 breast oncology surgery may only be granted if the health care establishment is organised in such a way as to enable it: 1° To prepare for oncology surgery, to have access to : a) On-site access to breast detection techniques; b) On-site access or by agreement, to sentinel lymph node techniques as part of a pre-established protocol with a nuclear medicine team; 2° Access, if necessary during…

Authorisation for thoracic oncology surgery with B2 may only be granted if the health care establishment has an organisation enabling it to guarantee on-site access to an extracorporeal circulation technique for the patients it treats.

Authorisation for oncological surgery of the otorhinolaryngeal and maxillofacial sphere with grades A and B may only be granted if the health care establishment has an organisation allowing access, on site or by agreement, to a maxillofacial prosthesis laboratory.

The surgical oncological management of a patient suffering from a rare cancer is carried out within an establishment holding an authorisation to carry out the activity of cancer treatment by surgical oncology which has on its site a centre of reference or a centre of competence for rare cancers labelled by the Institut national du cancer. By way of derogation from the previous paragraph, this surgical management may be carried…

For the post-operative care of the patients they treat, holders of the authorisation for thoracic oncology surgery with A2 mention mentioned in I of Article R. 6123-87-1, holders of the authorisation for complex oncology surgery with B mention mentioned in II of Article R. 6123-87-1 and the holder of the authorisation for surgery on children and adolescents under the age of eighteen with designation C referred to in III of…

When the holder of the surgical oncology authorisation implements a hybrid practice of surgical oncology management with the administration of a systemic cancer drug treatment intraoperatively or in the immediate aftermath of surgery, he must also be the holder of the authorisation for the systemic cancer drug treatment modality or be associated with a holder of this authorisation under the conditions set out in article R. 6123-90-1. A protocol for…

I.-By way of exception, an authorisation for surgical oncology with designation A derogating from the minimum annual activity stipulated in I of article R. 6123-91-4 may be granted or renewed when, after analysis of the needs of the population, access to other sites imposes excessive journey times or waiting times on a significant proportion of the population in the health region. The dispensatory authorisation referred to in the first paragraph…

I.- Exceptionally, by way of derogation from article R. 6123-87-1, for Corsica and the overseas departments and regions, and when these territories do not have the corresponding surgical oncology care offering with designation B, a complex or multidisciplinary therapeutic surgical oncology practice provided for in designation B may be carried out within an establishment which holds an authorisation for cancer treatment by surgical oncology with designation A and which complies…

I.- By way of derogation from the provisions of article R. 6123-87-1, a holder of a surgical oncology authorisation who has rare specific equipment included on a list drawn up by order of the Minister for Health may receive on its site members of a surgical team from another site authorised in the same region for one or more of the surgical oncology indications in order to benefit from the…

The holder of the authorisation for surgical oncology has an organisation that enables it, where necessary, to provide support to one or more other health establishments that hold a surgical authorisation but are not authorised for surgical oncology in application of the provisions of 1° and 2° of article R. 6123-90 and that contribute to the surgical care pathway for cancer patients upstream or downstream of the surgical oncology operation….